Latitude Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Latitude Advisors's LLY Position: Q3 2026 in Review
Latitude Advisors increased its Eli Lilly (LLY) stake by 1.7% in Q3 2026, buying an estimated $30.7K and bringing the position to 1,539 shares worth $1.78M. The position accounts for 0.55% of the portfolio, ranked #34.
Latitude Advisors first reported a position in LLY in Q4 2020 and has held it in 24 quarters since. The position peaked at $1.86M in Q1 2025. 2,846 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Latitude Advisors held 1,539 shares of Eli Lilly worth $1.78M as of Q3 2026.
- Latitude Advisors bought 26 Eli Lilly shares in Q3 2026, an estimated $30.7K.
- Eli Lilly made up 0.55% of Latitude Advisors's portfolio in Q3 2026, its #34 holding.
- Latitude Advisors first reported a position in Eli Lilly in Q4 2020 and has held it in 24 quarters since.
- Latitude Advisors's Eli Lilly position peaked at $1.86M in Q1 2025.
- 2,846 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Latitude Advisors's 13F filing for Q3 2026, filed 27 Oct 2026.